The global Cell-Free DNA (cfDNA) Testing Market is forecasted to be worth USD 22.41 Billion by 2027, according to a new report by Emergen Research. The global Cell-Free DNA (cfDNA) testing market is expected to grow significantly during the forecast period due to the increased incidence of cancers, rising prevalence of chromosome abnormalities in babies due to an increasing number of late pregnancy, and growing demand for non-invasive testing procedures. Besides, the increasing investments by governments to implement advanced therapeutic technology in hospitals is also expected to boost the market during the forecast period.
However, The expensive equipment and lack of skilled healthcare professionals are expected to restrain the market growth in the forecast timeframe
To know more about the report, visit @ https://www.emergenresearch.com/industry-report/cell-free-dna-market
The Global Cell-Free DNA (cfDNA) Testing Market Research Report provides a brief overview inclusive of the competitive landscape and key developments, policies, manufacturing costs, and processes. The report also provides the analysis of import/export, production and consumption ratio, supply and demand, cost, price, estimated revenue, and gross margins. The report further discusses in detail the driving factors influencing the growth of the market currently and in the coming years.
The report is a comprehensive research study of the global Cell-Free DNA (cfDNA) Testing market inclusive of the latest trends, growth factors, developments, opportunities, and competitive landscape. The research study includes an in-depth analysis of the market using advanced research methodologies such as SWOT analysis and Porter’s Five Forces analysis. The report is formulated with data gathered from primary and secondary research examined and validated by industry experts.
The report further explores the key business players along with their in-depth profiling, product catalog, and strategic business decisions. The key players studied in the report are:
Sequenom, Inc., Quest Diagnostics, Illumina Inc., Agilent Technologies, Inc., Guardant Health, Inc., Biodesix, Inc., Allenex AB, Roche Holdings AG, Biocept, Inc., and CareDx, Inc., among others.
Emergen Research has segmented the global Cell-Free DNA (cfDNA) Testing Market on the basis of type, technology, application, and region:
- Type Outlook (Revenue, USD Billion; 2017-2027)
- Cell-free fetal DNA (NIPT)
- Circulating tumor DNA
- Donor-derived cell-free DNA
- Technology Outlook (Revenue, USD Billion; 2017-2027)
- MPSS
- t-MPS
- SNP
- Others
- Application Outlook (Revenue, USD Billion; 2017-2027)
- Transplantation
- Gynecology
- Oncology
Regional Bifurcation of the Cell-Free DNA (cfDNA) Testing Market Includes:
- North America (U.S., Canada)
- Europe (U.K., Italy, Germany, France, Rest of EU)
- Asia Pacific (India, Japan, China, South Korea, Australia, Rest of APAC)
- Latin America (Chile, Brazil, Argentina, Rest of Latin America)
- Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of MEA).
Highlights of Table of Contents (TOC):
- Overview of Global Cell-Free DNA (cfDNA) Testing Market
- Competitive analysis of the Cell-Free DNA (cfDNA) Testing market
- Regional analysis of Global Cell-Free DNA (cfDNA) Testing market production and revenue
- Regional analysis of Global Cell-Free DNA (cfDNA) Testing market supply, consumption, and export & import
- Type-based market analysis of global Cell-Free DNA (cfDNA) Testing production, revenue, and price trends
- Application-based analysis of the global Cell-Free DNA (cfDNA) Testing market
- Manufacturer profiles, manufacturing cost, and upstream and downstream analysis of global Cell-Free DNA (cfDNA) Testing market
- Global Cell-Free DNA (cfDNA) Testing market forecast (2021-2028)
- Conclusion of the research report
- Appendix
Thank you for reading our report. For additional information on customization of the report, connect with us, and we will make sure you get a report tailored to your research needs.
About Us:
At Emergen Research, we believe in advancing with technology. We are a growing market research and strategy consulting company with an exhaustive knowledge base of cutting-edge and potentially market-disrupting technologies that are predicted to become more prevalent in the coming decade.
